Ticker Details
Amgen Inc. Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$196.25B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.66 | 1.11%
Avg Daily Range (30 D):	$3.76 | 1.09%
Avg Daily Range (90 D):	$3.95 | 1.13%

Institutional Daily Volume
Avg Daily Volume:	4.71M
Avg Daily Volume (30 D):	1.87M
Avg Daily Volume (90 D):	1.82M

Trade Size
Avg Trade Size (Sh.):	127
Avg Trade Size (Sh.) (30 D):	30
Avg Trade Size (Sh.) (90 D):	31

Institutional Trades
Total Institutional Trades:	115,447
Avg Institutional Trade:	$6.73M
Avg Institutional Trade (30 D):	$42.08M
Avg Institutional Trade (90 D):	$42.03M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	20

Market Closing Trades
Avg Closing Trade:	$70.27M
Avg Closing Trade (30 D):	$264.32M
Avg Closing Trade (90 D):	$228.34M
Avg Closing Volume:	396.01K

News

Jul 8, 2026 @ 11:28 AM BBH vs. XPH: Which Healthcare ETF Is Better for Be... Source: Sarah Sidlow

Jul 6, 2026 @ 6:29 PM The Dow Couldn't Keep Up With Chip Stocks on Monda... Source: Anders Bylund

Jun 30, 2026 @ 10:05 AM Alphabet Just Joined the Dow Jones Industrial Aver... Source: Patrick Sanders

Jun 23, 2026 @ 11:33 PM Amgen vs. Iovance Biotherapeutics: Which Healthcar... Source: Sara Appino

Jun 22, 2026 @ 5:00 PM Cutaneous Lupus Erythematosus Market to Expand at ... Source: Delveinsight

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$14.48	$3.37	$2.47
Diluted EPS	$14.38	$3.34	$2.46
Revenue	$37.22B	$8.62B	$9.87B
Gross Profit	$25.41B	$5.87B	$6.89B
Net Income / Loss	$7.8B	$1.82B	$1.33B
Operating Income / Loss	$10.57B	$2.67B	$2.72B
Cost of Revenue	$11.81B	$2.74B	$2.98B
Net Cash Flow	$3.23B	$2.91B	$-316M
PE Ratio